5.00 score from hupso.pl for:
kaletra.com



HTML Content


Titlekaletra® (iopinavir/ritonavir)

Length: 35, Words: 3
Description learn about kaletra® (iopinavir/ritonavir). official site from abbvie inc. includes safety and prescribing information.

Length: 124, Words: 15
Keywords pusty
Robots
Charset UTF-8
Og Meta - Title pusty
Og Meta - Description pusty
Og Meta - Site name pusty
Tytuł powinien zawierać pomiędzy 10 a 70 znaków (ze spacjami), a mniej niż 12 słów w długości.
Meta opis powinien zawierać pomiędzy 50 a 160 znaków (łącznie ze spacjami), a mniej niż 24 słów w długości.
Kodowanie znaków powinny być określone , UTF-8 jest chyba najlepszy zestaw znaków, aby przejść z powodu UTF-8 jest bardziej międzynarodowy kodowaniem.
Otwarte obiekty wykresu powinny być obecne w stronie internetowej (więcej informacji na temat protokołu OpenGraph: http://ogp.me/)

SEO Content

Words/Characters 1995
Text/HTML 54.90 %
Headings H1 2
H2 3
H3 0
H4 1
H5 0
H6 7
H1
your kaletra co-pay savings start here
for more information on kaletra co-pay cards
H2
save up to $100 a month*
1.800.633.9110
1.800.222.6885
H3
H4 you are leaving kaletra.com
H5
H6 important safety information1
what is the most important information i should know about kaletra?
who should not take kaletra?
what should i tell my doctor before taking kaletra?
what are the possible side effects of kaletra?
important safety information
what is the most important information i should know about kaletra?
strong
this is not health insurance.
1.
b
this is not health insurance.
1.
i
em this is not health insurance.
1.
Bolds strong 2
b 2
i 0
em 2
Zawartość strony internetowej powinno zawierać więcej niż 250 słów, z stopa tekst / kod jest wyższy niż 20%.
Pozycji używać znaczników (h1, h2, h3, ...), aby określić temat sekcji lub ustępów na stronie, ale zwykle, użyj mniej niż 6 dla każdego tagu pozycje zachować swoją stronę zwięzły.
Styl używać silnych i kursywy znaczniki podkreślić swoje słowa kluczowe swojej stronie, ale nie nadużywać (mniej niż 16 silnych tagi i 16 znaczników kursywy)

Statystyki strony

twitter:title pusty
twitter:description pusty
google+ itemprop=name pusty
Pliki zewnętrzne 7
Pliki CSS 2
Pliki javascript 5
Plik należy zmniejszyć całkowite odwołanie plików (CSS + JavaScript) do 7-8 maksymalnie.

Linki wewnętrzne i zewnętrzne

Linki 25
Linki wewnętrzne 13
Linki zewnętrzne 12
Linki bez atrybutu Title 25
Linki z atrybutem NOFOLLOW 0
Linki - Użyj atrybutu tytuł dla każdego łącza. Nofollow link jest link, który nie pozwala wyszukiwarkom boty zrealizują są odnośniki no follow. Należy zwracać uwagę na ich użytkowania

Linki wewnętrzne

important safety information #isi
/
/pdf/copay_card.pdf
#kaletra
www.fda.gov/medwatch
www.pparx.org
advertising choices
#isi
detailed important risk information #isi
javascript:void(0)
javascript:void(0)

Linki zewnętrzne

prescribing information http://www.rxabbvie.com/pdf/kaletratabpi.pdf
medication guide http://www.rxabbvie.com/pdf/kaletratab_medguide.pdf

www.abbviemedinfo.com

http://www.abbviemedinfo.com

www.abbviepaf.org

http://www.abbviepaf.org
full prescribing information http://www.rxabbvie.com/pdf/kaletratabpi.pdf
medication guide http://www.rxabbvie.com/pdf/kaletratab_medguide.pdf
legal notices/privacy policy http://www.abbvie.com/privacy.html
click here https://www.abbvie.com/contactus.html
privacy policy  |  http://www.abbvie.com/privacy.html
terms of use  |  http://www.abbvie.com/termsofuse.html
contact us  |  https://www.abbvie.com/contactus.html
http://www.abbvie.com

Zdjęcia

Zdjęcia 1
Zdjęcia bez atrybutu ALT 1
Zdjęcia bez atrybutu TITLE 1
Korzystanie Obraz ALT i TITLE atrybutu dla każdego obrazu.

Zdjęcia bez atrybutu TITLE

/content/images/copay-card.png

Zdjęcia bez atrybutu ALT

/content/images/copay-card.png

Ranking:


Alexa Traffic
Daily Global Rank Trend
Daily Reach (Percent)









Majestic SEO











Text on page:

important safety information prescribing information medication guide my journey with kaletra starts today models throughout are for illustrative purposes only. kaletra® (lopinavir/ritonavir) is a prescription hiv-1 medicine that is used with other hiv medicines to treat hiv-1 (human immunodeficiency virus) infection in adults and children 14 days of age and older. hiv is the virus that causes aids (acquired immune deficiency syndrome). kaletra is a type of hiv medicine called a protease inhibitor. kaletra contains two medicines: lopinavir and ritonavir. it is not known if kaletra is safe and effective in children under 14 days old. kaletra does not cure hiv infection or aids. people taking kaletra may develop infections or other conditions associated with hiv infection, including opportunistic infections (for example, pneumonia and herpes virus infections). your kaletra co-pay savings start here save up to $100 a month* if eligible, save up to $100 for kaletra per 30-day supply* for more information on kaletra co-pay cards patients: call 1-800-441-4987 - opt 5 pharmacists: call opus health at 1-800-364-4767 for instructions and assistance * eligibilitiy: offer not valid in massachusetts. available to patients with commercial prescription insurance coverage for kaletra. co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state or government-funded insurance programs (for example, medicare inclucing part d), medicare advantage, medigap, medicaid, tricare,, department of defense of veterans affairs programs) or where prohibitied by law. if at any time a patient begins receiving prescription drug coverage under any such federal, state or government-funded healthcare program, patient will no longer be able to use the kaletra card and patient must call opus health at 1-800-441-4987 - opt 5 to stop participation. patients may not seek reimbursement for value received from the kaletra co-pay program from any third-party payers. offer subject to change or discontinuance without notice. restrictions, including monthly maximums, may apply. this is not health insurance. abbvie medical information 1.800.633.9110 www.abbviemedinfo.com abbvie patient assistance foundation 1.800.222.6885 www.abbviepaf.org important safety information1 what is the most important information i should know about kaletra? kaletra may cause serious side effects, including: interactions with other medicines. it is important to know the medicines that should not be taken with kaletra. for more information, see “who should not take kaletra?” changes in your heart rhythm and the electrical activity of your heart can occur when taking kaletra. these changes can lead to serious heart problems. your risk for these problems may be higher if you already have a history of abnormal heart rhythm or other types of heart disease, or if you take other medicines that can affect your heart rhythm while you take kaletra. tell your doctor right away if you experience dizziness, lightheadedness, fainting, and/or a sensation of abnormal heartbeats. who should not take kaletra? do not take kaletra if you are allergic to kaletra or any of its ingredients, including lopinavir or ritonavir. skin rashes, some of them severe, can occur in people who take kaletra. tell your doctor if you had a rash when you took another medicine for hiv or if you notice any skin rash when you take kaletra. do not take kaletra if you take any of the following medicines: alfuzosin (uroxatral®); cisapride (propulsid®, quicksolv®); ergot containing medicines, including ergotamine (cafergot® and others), dihydroergotamine (d.h.e. 45® or migranal®), and methylergonovine (methergine®); lovastatin (advicor®, altoprev®, or mevacor®); midazolam oral syrup; lurasidone (latuda®); pimozide (orap®); rifampin (rifadin®, rifamate®, rifater®, or rimactane®); sildenafil (revatio®), when used for the treatment of pulmonary arterial hypertension; simvastatin (zocor®, vytorin®, or simcor®); products containing st. john’s wort (hypericum perforatum); or triazolam (halcion®). serious problems can happen if you or your child takes any of the medicines listed above with kaletra. what should i tell my doctor before taking kaletra? kaletra may not be right for you. tell your doctor about all of your medical conditions, including if you have any heart problems, including if you have a condition called congenital long qt syndrome; have or had pancreas problems, liver problems, including hepatitis b or hepatitis c, diabetes, hemophilia (people who take kaletra may have increased bleeding), or low potassium in your blood; or are pregnant or plan to become pregnant. if you take kaletra during pregnancy, you should talk with your doctor about how you can take part in an antiretroviral pregnancy registry. do not breastfeed, as it is not known if kaletra can be passed to the baby through your breast milk and whether it could harm your baby. also, mothers with hiv-1 should not breastfeed because hiv-1 can be passed to the baby in the breast milk. tell your doctor about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. many medicines interact with kaletra. do not start taking a new medicine without telling your doctor or pharmacist. your doctor can tell you if it is safe to take kaletra with other medicines. your doctor may need to change the dose of other medicines while you take kaletra. tell your doctor right away if you are taking: estrogen-based contraceptives (birth control pills and patches). you should use a different type or an extra form of birth control, since birth control pills or patches may not work as well while you take kaletra. talk to your doctor about how to prevent pregnancy while taking kaletra. medicines used for the treatment of erectile problems, such as avanafil (stendra®), sildenafil (viagra®), tadalafil (cialis®), or vardenafil (levitra®). there is an increased risk of certain problems when you take these medicines with kaletra, such as low blood pressure (dizziness or fainting), vision changes, and/or erections lasting more than 4 hours. tell your doctor right away if you experience any of these side effects. kaletra should not be taken once daily if you take carbamazepine (carbatrol®, epitol®, equetro®, tegretol®), phenobarbital (luminal®), phenytoin (dilantin®, phenytek®), efavirenz (atripla®, sustiva®), nevirapine (viramune®), or nelfinavir (viracept®). kaletra tablets should not be taken once daily if you are pregnant. you should not take kaletra oral solution if you are pregnant. kaletra oral solution contains propylene glycol and a large amount of alcohol. kaletra should not be given one time each day in children. when giving kaletra to your child, give kaletra exactly as prescribed. kaletra oral solution should not be given to babies younger than 14 days of age unless your doctor thinks it is right for your baby. babies taking kaletra oral solution may have side effects. call your doctor right away if your baby appears too sleepy or their breathing has changed. talk with your doctor if you take or plan to take metronidazole or disulfiram. you can have severe nausea and vomiting if you take these medicines with kaletra. this is not a complete list of medicines about which you should tell your doctor or pharmacist. for more information, refer to the kaletra medication guide. ask your doctor or pharmacist if you are not sure what medicines you are taking. know all the medicines that you take. keep a list of them to show doctors and pharmacists when you get a new medicine. do not start any new medicines while you are taking kaletra without first talking with your doctor. what are the possible side effects of kaletra? kaletra can cause serious side effects: kaletra may not be right for you. tell your doctor about all of your medical conditions. inflammation of the pancreas (pancreatitis), which may be serious and cause death, has occurred in some people who take kaletra. you have a higher chance of having pancreatitis if you have had it before. tell your doctor if you have nausea, vomiting, and/or abdominal pain, as these may be signs of pancreatitis. liver problems, including death, can happen in people who take kaletra. your doctor should do blood tests before and during your treatment with kaletra to check your liver function. some people with liver disease, such as hepatitis b or c, who take kaletra may have worsening liver disease. tell your doctor right away if you have any of the following signs and symptoms: loss of appetite, yellowing of skin or eyes (jaundice), dark-colored urine, pale-colored stools, itchy skin, and/or stomach area (abdominal) pain. new or more serious diabetes and high blood sugar (hyperglycemia) have occurred in some people who take protease inhibitors, including kaletra. tell your doctor if you notice an increase in thirst or urinate often while taking kaletra. changes in your immune system (immune reconstitution syndrome) can happen when you start taking hiv medicines. your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. call your doctor right away if you start having new symptoms after starting your hiv medicine. large increases in certain fat (triglycerides and cholesterol) levels in the blood have occurred in some people receiving kaletra. your doctor should do blood tests to check your cholesterol and triglyceride levels before you start taking kaletra and during your treatment. changes in body fat have been seen in some people who take anti-hiv therapy. the cause and long-term health effects of these conditions are not known at this time. increased bleeding has occurred in some people with hemophilia who take protease inhibitors, including kaletra. common side effects of kaletra include diarrhea, nausea, increased fats in blood (triglycerides or cholesterol), and vomiting. these are not all of the possible side effects of kaletra. this is the most important information to know about kaletra. for more information, talk with your doctor. kaletra tablets are a prescription medication. please see the full prescribing information, including the medication guide, for kaletra. you are encouraged to report negative side effects of prescription drugs to the fda. visit www.fda.gov/medwatch, or call 1-800-fda-1088. if you cannot afford your medication, contact www.pparx.org for assistance. you may also call 1-866-kaletra for more information, or abbvie customer service at 1-800-255-5162. reference: 1. kaletra [package insert]. north chicago, il: abbvie inc. legal notices/privacy policy. copyright 2013, abbvie inc., north chicago, illinois, u.s.a. if you have any questions about abbvie's kaletra.com website that have not been answered click here. this website and the information contained herein is intended for use by us residents only, is provided for informational purposes only and is not intended to replace a discussion with a healthcare provider. all decisions regarding patient care must be made with a healthcare provider and consider the unique characteristics of each patient. privacy policy | terms of use | contact us | advertising choices ©2017 abbvie inc. 1980508-1881418 north chicago, il 60064 january 2017 please expand for detailed important risk information. important safety information what is the most important information i should know about kaletra? kaletra may cause serious side effects, including: interactions with other medicines. it is important to know the medicines that should not be taken with kaletra. for more information, see “who should not take kaletra?” you are leaving kaletra.com the "continue" link below will take you out of the kaletra® (lopinavir/ritonavir) website operated by abbvie inc. you are now going to a third-party website. abbvie is providing this link. as a convenience to you, abbvie provides links from its websites to other third-party websites. information collected at third-party websites is not covered by our privacy policy, which applies solely to the information collected on this website. abbvie cannot guarantee the standards of every website link it provides or be responsible for the privacy practices or the content included on third-party websites. we encourage you to be aware when you leave this site and to read the privacy policy of any website that you may visit.


Here you find all texts from your page as Google (googlebot) and others search engines seen it.

Words density analysis:

Numbers of all words: 1926

One word

Two words phrases

Three words phrases

you - 5.56% (107)
kaletra - 3.89% (75)
the - 3.48% (67)
for - 2.8% (54)
our - 2.75% (53)
your - 2.49% (48)
not - 2.08% (40)
and - 1.92% (37)
take - 1.87% (36)
medicine - 1.51% (29)
doctor - 1.4% (27)
with - 1.35% (26)
are - 1.3% (25)
kaletra. - 1.25% (24)
medicines - 1.19% (23)
form - 1.09% (21)
information - 1.04% (20)
should - 0.99% (19)
have - 0.93% (18)
may - 0.93% (18)
use - 0.93% (18)
all - 0.83% (16)
can - 0.78% (15)
any - 0.78% (15)
out - 0.78% (15)
including - 0.73% (14)
tell - 0.73% (14)
hiv - 0.67% (13)
abbvie - 0.67% (13)
taking - 0.62% (12)
other - 0.62% (12)
site - 0.62% (12)
website - 0.57% (11)
who - 0.57% (11)
side - 0.57% (11)
about - 0.52% (10)
effects - 0.52% (10)
people - 0.52% (10)
now - 0.52% (10)
patient - 0.52% (10)
right - 0.52% (10)
problems - 0.47% (9)
important - 0.47% (9)
when - 0.47% (9)
part - 0.47% (9)
know - 0.47% (9)
that - 0.47% (9)
call - 0.47% (9)
start - 0.42% (8)
per - 0.42% (8)
more - 0.42% (8)
this - 0.42% (8)
these - 0.42% (8)
change - 0.42% (8)
heart - 0.42% (8)
age - 0.42% (8)
blood - 0.36% (7)
care - 0.36% (7)
infection - 0.36% (7)
kaletra? - 0.36% (7)
health - 0.36% (7)
cause - 0.36% (7)
serious - 0.36% (7)
prescription - 0.36% (7)
some - 0.36% (7)
while - 0.31% (6)
occur - 0.31% (6)
away - 0.31% (6)
information, - 0.31% (6)
harm - 0.31% (6)
day - 0.31% (6)
low - 0.31% (6)
increase - 0.31% (6)
medication - 0.26% (5)
changes - 0.26% (5)
pharmacist - 0.26% (5)
program - 0.26% (5)
third-party - 0.26% (5)
new - 0.26% (5)
safe - 0.26% (5)
oral - 0.26% (5)
able - 0.26% (5)
baby - 0.26% (5)
see - 0.26% (5)
privacy - 0.26% (5)
what - 0.26% (5)
here - 0.26% (5)
treat - 0.26% (5)
liver - 0.26% (5)
condition - 0.26% (5)
problems, - 0.26% (5)
child - 0.26% (5)
talk - 0.26% (5)
inc. - 0.21% (4)
policy - 0.21% (4)
fat - 0.21% (4)
link - 0.21% (4)
websites - 0.21% (4)
ergot - 0.21% (4)
occurred - 0.21% (4)
solution - 0.21% (4)
breast - 0.21% (4)
pregnant - 0.21% (4)
taken - 0.21% (4)
long - 0.21% (4)
and/or - 0.21% (4)
before - 0.21% (4)
treatment - 0.21% (4)
notice - 0.21% (4)
increased - 0.21% (4)
skin - 0.21% (4)
medicines. - 0.21% (4)
lopinavir - 0.21% (4)
assistance - 0.21% (4)
co-pay - 0.21% (4)
immune - 0.21% (4)
conditions - 0.21% (4)
time - 0.21% (4)
hiv-1 - 0.21% (4)
infections - 0.21% (4)
such - 0.21% (4)
patients - 0.21% (4)
pancreatitis - 0.16% (3)
how - 0.16% (3)
st. - 0.16% (3)
happen - 0.16% (3)
which - 0.16% (3)
triglyceride - 0.16% (3)
protease - 0.16% (3)
hepatitis - 0.16% (3)
list - 0.16% (3)
vomiting - 0.16% (3)
pregnant. - 0.16% (3)
during - 0.16% (3)
pregnancy - 0.16% (3)
birth - 0.16% (3)
nausea - 0.16% (3)
been - 0.16% (3)
has - 0.16% (3)
too - 0.16% (3)
give - 0.16% (3)
insurance - 0.16% (3)
type - 0.16% (3)
interact - 0.16% (3)
known - 0.16% (3)
control - 0.16% (3)
high - 0.16% (3)
under - 0.16% (3)
cholesterol - 0.16% (3)
safety - 0.16% (3)
medical - 0.16% (3)
without - 0.16% (3)
days - 0.16% (3)
only - 0.16% (3)
used - 0.16% (3)
risk - 0.16% (3)
virus - 0.16% (3)
rhythm - 0.16% (3)
children - 0.16% (3)
had - 0.16% (3)
most - 0.16% (3)
rash - 0.16% (3)
guide - 0.16% (3)
receiving - 0.16% (3)
healthcare - 0.16% (3)
chicago, - 0.16% (3)
north - 0.16% (3)
from - 0.16% (3)
websites. - 0.1% (2)
tests - 0.1% (2)
check - 0.1% (2)
signs - 0.1% (2)
abdominal - 0.1% (2)
nausea, - 0.1% (2)
diabetes - 0.1% (2)
also - 0.1% (2)
having - 0.1% (2)
death, - 0.1% (2)
called - 0.1% (2)
possible - 0.1% (2)
doctor. - 0.1% (2)
medicine. - 0.1% (2)
get - 0.1% (2)
collected - 0.1% (2)
encourage - 0.1% (2)
prescribing - 0.1% (2)
purposes - 0.1% (2)
syndrome) - 0.1% (2)
inhibitors, - 0.1% (2)
intended - 0.1% (2)
cannot - 0.1% (2)
aids - 0.1% (2)
visit - 0.1% (2)
fda. - 0.1% (2)
please - 0.1% (2)
include - 0.1% (2)
bleeding - 0.1% (2)
kaletra.com - 0.1% (2)
levels - 0.1% (2)
cholesterol) - 0.1% (2)
(triglycerides - 0.1% (2)
symptoms - 0.1% (2)
provides - 0.1% (2)
time. - 0.1% (2)
provider - 0.1% (2)
body - 0.1% (2)
2017 - 0.1% (2)
(lopinavir/ritonavir) - 0.1% (2)
begin - 0.1% (2)
kaletra® - 0.1% (2)
contact - 0.1% (2)
system - 0.1% (2)
website. - 0.1% (2)
deficiency - 0.1% (2)
pharmacists - 0.1% (2)
once - 0.1% (2)
sure - 0.1% (2)
state - 0.1% (2)
you. - 0.1% (2)
offer - 0.1% (2)
available - 0.1% (2)
sildenafil - 0.1% (2)
ergotamine - 0.1% (2)
medicines, - 0.1% (2)
containing - 0.1% (2)
coverage - 0.1% (2)
following - 0.1% (2)
them - 0.1% (2)
reimbursement - 0.1% (2)
its - 0.1% (2)
federal, - 0.1% (2)
experience - 0.1% (2)
opt - 0.1% (2)
government-funded - 0.1% (2)
programs - 0.1% (2)
medicare - 0.1% (2)
drug - 0.1% (2)
disease, - 0.1% (2)
abnormal - 0.1% (2)
higher - 0.1% (2)
will - 0.1% (2)
card - 0.1% (2)
must - 0.1% (2)
kaletra?” - 0.1% (2)
effects, - 0.1% (2)
“who - 0.1% (2)
including: - 0.1% (2)
opus - 0.1% (2)
1-800-441-4987 - 0.1% (2)
refer - 0.1% (2)
certain - 0.1% (2)
severe - 0.1% (2)
babies - 0.1% (2)
contains - 0.1% (2)
each - 0.1% (2)
one - 0.1% (2)
given - 0.1% (2)
large - 0.1% (2)
medicines: - 0.1% (2)
tablets - 0.1% (2)
daily - 0.1% (2)
interactions - 0.1% (2)
effects. - 0.1% (2)
than - 0.1% (2)
patches - 0.1% (2)
pancreas - 0.1% (2)
ritonavir. - 0.1% (2)
pills - 0.1% (2)
pharmacist. - 0.1% (2)
breastfeed - 0.1% (2)
baby. - 0.1% (2)
milk - 0.1% (2)
through - 0.1% (2)
passed - 0.1% (2)
(for - 0.1% (2)
plan - 0.1% (2)
example, - 0.1% (2)
save - 0.1% (2)
hemophilia - 0.1% (2)
$100 - 0.1% (2)
read - 0.1% (2)
if you - 1.4% (27)
your doctor - 1.3% (25)
take kaletra - 0.88% (17)
you take - 0.67% (13)
of the - 0.57% (11)
should not - 0.57% (11)
tell your - 0.57% (11)
you are - 0.52% (10)
not be - 0.47% (9)
side effects - 0.47% (9)
taking kaletra - 0.42% (8)
with kaletra - 0.42% (8)
who take - 0.42% (8)
take kaletra. - 0.36% (7)
or more - 0.36% (7)
you have - 0.36% (7)
kaletra may - 0.36% (7)
is not - 0.36% (7)
doctor right - 0.31% (6)
for more - 0.31% (6)
away if - 0.31% (6)
some people - 0.31% (6)
not take - 0.31% (6)
when you - 0.31% (6)
right away - 0.31% (6)
people who - 0.31% (6)
have a - 0.31% (6)
in some - 0.26% (5)
more information, - 0.26% (5)
kaletra or - 0.26% (5)
doctor about - 0.26% (5)
with kaletra. - 0.26% (5)
effects of - 0.26% (5)
the medicines - 0.26% (5)
to the - 0.26% (5)
any of - 0.26% (5)
other medicines - 0.26% (5)
is the - 0.21% (4)
kaletra? kaletra - 0.21% (4)
be taken - 0.21% (4)
occurred in - 0.21% (4)
with your - 0.21% (4)
oral solution - 0.21% (4)
you should - 0.21% (4)
all of - 0.21% (4)
medicines that - 0.21% (4)
doctor if - 0.21% (4)
kaletra oral - 0.21% (4)
kaletra. tell - 0.21% (4)
with other - 0.21% (4)
may not - 0.21% (4)
the kaletra - 0.21% (4)
while you - 0.21% (4)
abbvie inc. - 0.21% (4)
for the - 0.21% (4)
right for - 0.16% (3)
taking kaletra. - 0.16% (3)
can happen - 0.16% (3)
birth control - 0.16% (3)
of your - 0.16% (3)
may have - 0.16% (3)
talk with - 0.16% (3)
you can - 0.16% (3)
about all - 0.16% (3)
such as - 0.16% (3)
are not - 0.16% (3)
new medicine - 0.16% (3)
or pharmacist - 0.16% (3)
have any - 0.16% (3)
important safety - 0.16% (3)
14 days - 0.16% (3)
you start - 0.16% (3)
most important - 0.16% (3)
cause serious - 0.16% (3)
third-party websites - 0.16% (3)
start taking - 0.16% (3)
of kaletra - 0.16% (3)
this is - 0.16% (3)
to know - 0.16% (3)
kaletra. for - 0.16% (3)
kaletra co-pay - 0.16% (3)
changes in - 0.16% (3)
your heart - 0.16% (3)
not known - 0.16% (3)
may be - 0.16% (3)
north chicago, - 0.16% (3)
know about - 0.16% (3)
who should - 0.16% (3)
chicago, il - 0.16% (3)
this website - 0.1% (2)
and the - 0.1% (2)
a healthcare - 0.1% (2)
website that - 0.1% (2)
list of - 0.1% (2)
medicines with - 0.1% (2)
kaletra. this - 0.1% (2)
website. abbvie - 0.1% (2)
take these - 0.1% (2)
and vomiting - 0.1% (2)
to take - 0.1% (2)
or plan - 0.1% (2)
information collected - 0.1% (2)
the privacy - 0.1% (2)
third-party websites. - 0.1% (2)
of age - 0.1% (2)
you to - 0.1% (2)
possible side - 0.1% (2)
increased bleeding - 0.1% (2)
that you - 0.1% (2)
has occurred - 0.1% (2)
hepatitis b - 0.1% (2)
your treatment - 0.1% (2)
and during - 0.1% (2)
do blood - 0.1% (2)
doctor should - 0.1% (2)
kaletra. your - 0.1% (2)
protease inhibitors, - 0.1% (2)
including kaletra. - 0.1% (2)
an increase - 0.1% (2)
your immune - 0.1% (2)
have been - 0.1% (2)
inhibitors, including - 0.1% (2)
you. tell - 0.1% (2)
call your - 0.1% (2)
have occurred - 0.1% (2)
the possible - 0.1% (2)
check your - 0.1% (2)
during your - 0.1% (2)
your doctor. - 0.1% (2)
to check - 0.1% (2)
medicines while - 0.1% (2)
take protease - 0.1% (2)
of them - 0.1% (2)
people with - 0.1% (2)
be passed - 0.1% (2)
kaletra to - 0.1% (2)
about kaletra? - 0.1% (2)
federal, state - 0.1% (2)
or government-funded - 0.1% (2)
1-800-441-4987 - - 0.1% (2)
to change - 0.1% (2)
information i - 0.1% (2)
should know - 0.1% (2)
side effects, - 0.1% (2)
state or - 0.1% (2)
including: interactions - 0.1% (2)
medicines. it - 0.1% (2)
is important - 0.1% (2)
that should - 0.1% (2)
taken with - 0.1% (2)
see “who - 0.1% (2)
prescription drug - 0.1% (2)
receiving prescription - 0.1% (2)
can occur - 0.1% (2)
hiv infection - 0.1% (2)
hiv medicines - 0.1% (2)
days of - 0.1% (2)
kaletra is - 0.1% (2)
if kaletra - 0.1% (2)
is safe - 0.1% (2)
in children - 0.1% (2)
or other - 0.1% (2)
to patients - 0.1% (2)
with hiv - 0.1% (2)
(for example, - 0.1% (2)
call opus - 0.1% (2)
health at - 0.1% (2)
available to - 0.1% (2)
for kaletra. - 0.1% (2)
take kaletra?” - 0.1% (2)
abnormal heart - 0.1% (2)
be given - 0.1% (2)
of these - 0.1% (2)
medicines you - 0.1% (2)
not start - 0.1% (2)
or pharmacist. - 0.1% (2)
medicines. your - 0.1% (2)
control pills - 0.1% (2)
these medicines - 0.1% (2)
side effects. - 0.1% (2)
kaletra® (lopinavir/ritonavir) - 0.1% (2)
kaletra should - 0.1% (2)
taken once - 0.1% (2)
daily if - 0.1% (2)
kaletra tablets - 0.1% (2)
once daily - 0.1% (2)
are pregnant. - 0.1% (2)
your baby. - 0.1% (2)
kaletra can - 0.1% (2)
and/or a - 0.1% (2)
treatment of - 0.1% (2)
kaletra if - 0.1% (2)
in people - 0.1% (2)
rash when - 0.1% (2)
you notice - 0.1% (2)
kaletra. do - 0.1% (2)
the following - 0.1% (2)
or your - 0.1% (2)
known if - 0.1% (2)
be right - 0.1% (2)
for you. - 0.1% (2)
your medical - 0.1% (2)
including if - 0.1% (2)
liver problems, - 0.1% (2)
plan to - 0.1% (2)
about how - 0.1% (2)
site and - 0.1% (2)
tell your doctor - 0.57% (11)
away if you - 0.31% (6)
not take kaletra - 0.31% (6)
your doctor right - 0.31% (6)
for more information - 0.31% (6)
right away if - 0.31% (6)
if you take - 0.31% (6)
if you have - 0.31% (6)
should not be - 0.31% (6)
people who take - 0.31% (6)
doctor right away - 0.31% (6)
for more information, - 0.26% (5)
in some people - 0.26% (5)
if you are - 0.26% (5)
you have a - 0.26% (5)
you take kaletra - 0.26% (5)
your doctor about - 0.26% (5)
who take kaletra - 0.26% (5)
your doctor if - 0.21% (4)
you take kaletra. - 0.21% (4)
doctor if you - 0.21% (4)
occurred in some - 0.21% (4)
kaletra oral solution - 0.21% (4)
side effects of - 0.21% (4)
kaletra. tell your - 0.21% (4)
talk with your - 0.16% (3)
you are taking - 0.16% (3)
who take kaletra. - 0.16% (3)
doctor about all - 0.16% (3)
you have any - 0.16% (3)
important safety information - 0.16% (3)
with other medicines. - 0.16% (3)
the medicines that - 0.16% (3)
the most important - 0.16% (3)
some people who - 0.16% (3)
take kaletra. tell - 0.16% (3)
most important information - 0.16% (3)
not take kaletra? - 0.16% (3)
during your treatment - 0.1% (2)
be taken once - 0.1% (2)
the possible side - 0.1% (2)
inhibitors, including kaletra. - 0.1% (2)
birth control pills - 0.1% (2)
used for the - 0.1% (2)
who take protease - 0.1% (2)
kaletra. your doctor - 0.1% (2)
you take these - 0.1% (2)
kaletra should not - 0.1% (2)
daily if you - 0.1% (2)
these medicines with - 0.1% (2)
and during your - 0.1% (2)
to check your - 0.1% (2)
taken once daily - 0.1% (2)
should do blood - 0.1% (2)
kaletra. this is - 0.1% (2)
your doctor should - 0.1% (2)
you are pregnant. - 0.1% (2)
your immune system - 0.1% (2)
protease inhibitors, including - 0.1% (2)
do blood tests - 0.1% (2)
or plan to - 0.1% (2)
doctor or pharmacist. - 0.1% (2)
about kaletra? kaletra - 0.1% (2)
not take kaletra?” - 0.1% (2)
see “who should - 0.1% (2)
taken with kaletra. - 0.1% (2)
important to know - 0.1% (2)
medicines. it is - 0.1% (2)
interactions with other - 0.1% (2)
side effects, including: - 0.1% (2)
may cause serious - 0.1% (2)
i should know - 0.1% (2)
of abnormal heart - 0.1% (2)
what is the - 0.1% (2)
federal, state or - 0.1% (2)
state or government-funded - 0.1% (2)
available to patients - 0.1% (2)
opus health at - 0.1% (2)
1-800-441-4987 - opt - 0.1% (2)
save up to - 0.1% (2)
is not known - 0.1% (2)
changes in your - 0.1% (2)
do not take - 0.1% (2)
a new medicine - 0.1% (2)
you. tell your - 0.1% (2)
all of the - 0.1% (2)
passed to the - 0.1% (2)
be passed to - 0.1% (2)
14 days of - 0.1% (2)
take kaletra may - 0.1% (2)
hepatitis b or - 0.1% (2)
liver problems, including - 0.1% (2)
of your medical - 0.1% (2)
be right for - 0.1% (2)
kaletra if you - 0.1% (2)
kaletra may not - 0.1% (2)
the treatment of - 0.1% (2)
of the following - 0.1% (2)
take kaletra if - 0.1% (2)
kaletra. do not - 0.1% (2)
when you take - 0.1% (2)
if you notice - 0.1% (2)
rash when you - 0.1% (2)
in people who - 0.1% (2)
with your doctor. - 0.1% (2)

Here you can find chart of all your popular one, two and three word phrases. Google and others search engines means your page is about words you use frequently.

Copyright © 2015-2016 hupso.pl. All rights reserved. FB | +G | Twitter

Hupso.pl jest serwisem internetowym, w którym jednym kliknieciem możesz szybko i łatwo sprawdź stronę www pod kątem SEO. Oferujemy darmowe pozycjonowanie stron internetowych oraz wycena domen i stron internetowych. Prowadzimy ranking polskich stron internetowych oraz ranking stron alexa.